ATRA icon

Atara Biotherapeutics

37 hedge funds and large institutions have $12.4M invested in Atara Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 11 closing their positions.

Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
13
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Russell Investments Group
26
Russell Investments Group
United Kingdom
$2.19K 368 -351 -49%
Lazard Asset Management
27
Lazard Asset Management
New York
$2K 368 -76 -17%
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$1.28K 216
RBI
29
Raiffeisen Bank International
Austria
$1.19K 200 +200 New
TRCT
30
Tower Research Capital (TRC)
New York
$1.1K 185 +115 +164%
IA
31
IFP Advisors
Florida
$1.07K 180
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$1.04K 175
BT
33
Banque Transatlantique
France
$966 176
Group One Trading
34
Group One Trading
Illinois
$879 148 -246 -62%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$297 50 -11 -18%
Osaic Holdings
36
Osaic Holdings
Arizona
$59 10 -600 -98%
Citadel Advisors
37
Citadel Advisors
Florida
-267,353 Closed
Marshall Wace
38
Marshall Wace
United Kingdom
-24,958 Closed
CSS
39
Cubist Systematic Strategies
Connecticut
-12,682 Closed
Millennium Management
40
Millennium Management
New York
-10,133 Closed
PAS
41
Point72 Asia (Singapore)
Singapore
-3,603 Closed
RS
42
R Squared
Hong Kong
-240 Closed
PD
43
Point72 (DIFC)
United Arab Emirates
-68 Closed
GI
44
GAMMA Investing
California
-56 Closed
EWA
45
EverSource Wealth Advisors
Alabama
-35 Closed
AIP
46
Alexis Investment Partners
Texas
-28 Closed
Citigroup
47
Citigroup
New York
-2 Closed
CFGS
48
Concourse Financial Group Securities
Alabama
Barclays
49
Barclays
United Kingdom
$0 1 +1 New